Anavex Life Sciences Corp... (AVXL)
NASDAQ: AVXL
· Real-Time Price · USD
9.91
-0.20 (-1.98%)
At close: Aug 15, 2025, 3:59 PM
9.95
0.30%
After-hours: Aug 15, 2025, 04:10 PM EDT
-1.98% (1D)
| Bid | 9.9 |
| Market Cap | 851.64M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -47.14M |
| EPS (ttm) | -0.57 |
| PE Ratio (ttm) | -17.39 |
| Forward PE | 7.85 |
| Analyst | Buy |
| Ask | 10.54 |
| Volume | 805,843 |
| Avg. Volume (20D) | 1,050,401 |
| Open | 10.00 |
| Previous Close | 10.11 |
| Day's Range | 9.91 - 10.25 |
| 52-Week Range | 4.93 - 14.44 |
| Beta | 0.80 |
About AVXL
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol AVXL
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for AVXL stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts7 months ago
+8.21%
Anavex Life Sciences shares are trading higher aft...
Unlock content with
Pro Subscription
7 months ago
+29.55%
Anavex Life Sciences shares are trading higher after the company announced better-than-expected Q4 financial results.
2 days ago · seekingalpha.com
Anavex Life Sciences Corp. (AVXL) Q3 2025 Earnings Call TranscriptAnavex Life Sciences Corp. (NASDAQ:AVXL ) Q3 2025 Earnings Conference Call August 12, 2025 8:00 AM ET Company Participants Christopher U. Missling - President, CEO, Secretary & Director Clint Tomlinso...
3 months ago · seekingalpha.com
The Unusual Effects Of Anavex's Blarcamesine On Alzheimer's Disease (Upgrade)Blarcamesine shows limited effectiveness against mild Alzheimer's disease, but not against moderate Alzheimer's. However, it does appear effective when started early. These result could lead to Europ...